The Sydney Morning Herald logo

CSL Limited

Advertisement
Wall Street had its best day in weeks.

ASX bounces to 50-day high as CBA, AGL soar

Shares in Commonwealth Bank bounced after it revealed a $5.4 billion half-year profit leading the ASX higher.

  • Staff reporter

Latest

US Health Secretary Robert F. Kennedy Jr: Having an anti-vaxxer in charge of America’s health system has been one of the factors hitting CSL’s performance.

How RFK, China and leadership woes became a $4b storm for this Australian corporate giant

CSL’s share price has now halved in 18 months, shredding more than $70 billion of shareholder wealth after the latest writedowns and operational struggles. 

  • Colin Kruger
CBA boss Matt Comyn, Helen Lofthouse of the ASX and CSL’s former chief Paul McKenzie.

The good, the bad and the very ugly of profit season

It’s still early in the earnings season, but already we have two chief executive beheadings, while one of the big four banks has posted a stellar result.

  • Elizabeth Knight
Outgoing CSL boss Paul McKenzie.

Boss of $83b giant CSL exits abruptly

Australian pharmaceuticals heavyweight CSL says its chief executive Paul McKenzie is leaving the company with immediate effect.

  • Clancy Yeates
Haemophilia is a disease written into the genes.

This gene therapy costs $5 million a dose. Is it worth the price?

A new wave of gene therapy treatments offer a new lease on life for people with inherited diseases such as haemophilia. But there’s a $5 million problem.

  • Liam Mannix
President Trump and Robert F. Kennedy at a Make America Healthy Again event in May.

How Trump’s antivaxxers helped trigger Aussie giant’s $50b implosion

The deadliest US flu season in decades was expected to immunise CSL’s vaccine business from a growing anti-vaxxer sentiment. That’s not how it has played out.

  • Colin Kruger
Advertisement
Robert F. Kennedy Jr has espoused misinformation around vaccine safety, including a discredited theory that childhood vaccines cause autism.

Aussie giant takes $17b hit as more Americans shun vaccines

A further plunge in US vaccination rates since the appointment of vaccine sceptic Robert F. Kennedy Jr has sparked a fresh earnings blow to biotech giant CSL.

  • Colin Kruger
US President Donald Trump announced 100 per cent tariffs on pharamceuticals via Truth Social.

Mission critical: Australia keen to lock in new US deal before Trump meeting

Canberra is negotiating with the president’s lieutenants to guarantee the Americans access to the elements needed to build everything from smartphones to fighter jets.

  • Paul Sakkal and Nick Newling
US President Donald Trump announced 100 per cent tariffs on pharamceuticals via Truth Social.

Break ground by Wednesday or else: Trump imposes 100 per cent tariff on pharmaceuticals

Shares in domestic biotechnology giant CSL dropped 3.6 per cent after Trump announced the tariff on Truth Social.

  • Nick Newling
US stocks got some lift from the easing pressure in the bond market.

ASX starts week in the red; miners weak, CBA slips

The Australian sharemarket pared early losses but has started the week lower as miners weigh on the bourse.

  • Staff reporter